Myeloid Malignancies
20 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Off-the-shelf NK Cells + SCT for Myeloid Malignancies (NCT05115630) | M.D. Anderson Cancer Center | 2022-04-08 |
| Study of Magrolimab Combinations in Participants With Myeloid Malignancies (NCT04778410) | Gilead Sciences | 2021-06-28 |
| Post Transplant High-Dose Cy as GvHD Prophylaxis in 1 HLA Mismatched Unrelated HSCT for Myeloid Malignancies (NCT03270748) | Gruppo Italiano Trapianto di Midollo Osseo | 2020-01-15 |
| A Clinical Research of CD33-Targeted CAR-T in Myeloid Malignancies (NCT02958397) | Southwest Hospital, China | 2016-10-01 |
| Ph2 NK Cell Enriched DCIs w/wo RLR9 Agonist, DUK-CPG-001 From Donors Following Allogeneic SCT (NCT02452697) | Cristina Gasparetto | 2016-06-08 |
| Imetelstat Sodium in Treating Participants With Primary or Secondary Myelofibrosis (NCT01731951) | Geron Corporation | 2012-10-29 |
| Fludarabine and Busulfan vs. Fludarabine, Busulfan and Total Body Irradiation (NCT01366612) | Hackensack Meridian Health | 2010-06-16 |
Track Myeloid Malignancies automatically
Every clearance here is in the API, with alerts when new ones post.